Umang Pravinchandra Kotak

Umang Pravinchandra Kotak

Active Director Director DIN 08692072
DIN 08692072 First appointment Feb 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Umang Pravinchandra Kotak

Data last updated:

Umang Pravinchandra Kotak is a Director at Ojas Pharma And Research Private Limited (since 2020). The company operates in Pharma.

DIN 08692072
Primary Designation Director
Industry Pharma
First Appointment 06 Feb 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Feb 20202020Active

Board colleagues of Umang Pravinchandra Kotak

Directorship timeline

Open interactive timeline →
Ojas Pharma And Research Private Limited
Premium access

Shareholding and investment profile for Umang Pravinchandra Kotak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Umang Pravinchandra Kotak

Umang Pravinchandra Kotak currently holds 1 directorship: Ojas Pharma And Research Private Limited (Director, since 06 Feb 2020).

Umang Pravinchandra Kotak was first appointed on 06 Feb 2020 as Director at Ojas Pharma And Research Private Limited.

The current boards of Umang Pravinchandra Kotak's companies include Uday Gunwantrai Somani (Ojas Pharma And Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available